Cargando…
The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma
Background: Reliable biomarkers are rare for renal cell carcinoma (RCC) treatment selection. We aimed to discover novel biomarkers for precision medicine. The iron-regulating hormone hepcidin (HAMP) was reportedly increased in RCC patient sera and tissues. However, its potential implication as a pro...
Autores principales: | Huang, Jian, Liu, Wang, Song, Shiqi, Li, Jean C., Gan, Kaimei, Shen, Chunxiao, Holzbeierlein, Jeffrey, Li, Benyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757070/ https://www.ncbi.nlm.nih.gov/pubmed/36532749 http://dx.doi.org/10.3389/fphar.2022.1080055 |
Ejemplares similares
-
Iron, anemia and hepcidin in malaria
por: Spottiswoode, Natasha, et al.
Publicado: (2014) -
Iron, hepcidin, and the metal connection
por: Loréal, Olivier, et al.
Publicado: (2014) -
Iron deficiency in the elderly population, revisited in the hepcidin era
por: Busti, Fabiana, et al.
Publicado: (2014) -
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
por: Poli, Maura, et al.
Publicado: (2014) -
Upregulation of brain hepcidin in prion diseases: Short title: Hepcidin and brain iron accumulation
por: Chaudhary, Suman, et al.
Publicado: (2021)